The S&P 500 index is a popular choice for investors looking for stability, but not every large-cap stock is a good investment. Arthur J. Gallagher (AJG), with a market capitalization of $56.93 billion, is identified as a strong buy due to its extensive operations in insurance brokerage and consulting across approximately 130 countries. Conversely, Bio-Techne (TECH), valued at $9.27 billion, is struggling with organic revenue growth and a significant decline in free cash flow margins, making it a stock to avoid. Similarly, Gartner (IT), with a market cap of $10.44 billion, is projected to have flat sales over the next year and has also seen a decrease in its free cash flow margin. Investors are advised to conduct thorough research before adding these stocks to their portfolios.